Home Cart 0 Sign in  
X

[ CAS No. 1053228-28-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1053228-28-6
Chemical Structure| 1053228-28-6
Chemical Structure| 1053228-28-6
Structure of 1053228-28-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1053228-28-6 ]

Related Doc. of [ 1053228-28-6 ]

Alternatived Products of [ 1053228-28-6 ]

Product Details of [ 1053228-28-6 ]

CAS No. :1053228-28-6 MDL No. :MFCD13193620
Formula : C6H2Cl3N3 Boiling Point : -
Linear Structure Formula :- InChI Key :YUKWSCQSOXCSES-UHFFFAOYSA-N
M.W : 222.46 Pubchem ID :52987746
Synonyms :

Calculated chemistry of [ 1053228-28-6 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 48.92
TPSA : 41.57 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.38 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.82
Log Po/w (XLOGP3) : 3.21
Log Po/w (WLOGP) : 2.92
Log Po/w (MLOGP) : 1.7
Log Po/w (SILICOS-IT) : 3.48
Consensus Log Po/w : 2.63

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.8
Solubility : 0.0355 mg/ml ; 0.00016 mol/l
Class : Soluble
Log S (Ali) : -3.76
Solubility : 0.0391 mg/ml ; 0.000176 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.39
Solubility : 0.00898 mg/ml ; 0.0000404 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.65

Safety of [ 1053228-28-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1053228-28-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1053228-28-6 ]
  • Downstream synthetic route of [ 1053228-28-6 ]

[ 1053228-28-6 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 90213-66-4 ]
  • [ 1053228-29-7 ]
  • [ 1053228-28-6 ]
Reference: [1] Helvetica Chimica Acta, 2008, vol. 91, # 6, p. 1083 - 1105
  • 2
  • [ 90213-66-4 ]
  • [ 1053228-28-6 ]
YieldReaction ConditionsOperation in experiment
93% With N-chloro-succinimide In tetrahydrofuran; dichloromethane at 90℃; for 2.5 h; Microwave irradiation To a solution of 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine (2.0 g, 10.64 mmol) indichloromethane/tetrahydrofuran (DCM/THF) (15 mL/6 mL) was added NCS (1 .70g, 12.76mmol). The mixture was heated to 90 °C under microwave irradiation for 2.5 hr. The solvent was removed in vacuo and the crude product was purified by flash column chromatography using a9:1 v/v Hexane:Ethyl acetate to afford the title compound (2.2 g, 93percent yield) as a white crystalline solid. MS m/z 223.48 [M+1].
93.4% With N-chloro-succinimide In N,N-dimethyl-formamide at 20℃; for 24 h; 2,4-dicUoro-7H-pyrrolo[2,3-d]pyrimidine (5.0 g, 26.6 mmol) and N- cWorosuccinimide (5.3 g, 39.9 mmol) were dissolved in N,N-dimethylformamide (50.0 mL) and then stirred at room temperature for 24 hours. The organic layer was isolated, treated with magnesium sulfate, filtered, and then concentrated under reduced pressure. The residue was isolated by column chromatography to obtain a title compound (5.5 g, yield: 93.4percent). H NMR (500MHz, CD3OD) δ 7.54(s, 1H)
63.37% With N-chloro-succinimide In tetrahydrofuran; dichloromethane at 25 - 90℃; for 2.5 h; Microwave irradiation To a mixture of 2,4-dicholo-7H-pyrrolof2,3- djpyrimidine (1 g, 5.32 mmol) in THF (3 mL) and DCM ( 12 mL) was added NCS (852 mg, 6.38 mmol) in one portion at 25°C. The mixture was stirred under microwave at 90 °C for 2.5 h. LC/MS showed the reaction was completed. Two new peaks were shown on LC/MS and 74percent of desired (M+Ff" = 221 .9) was detected. The mixture was added to brine and extracted with DCM. The organics were dried over anhydrous Na^SO, and concentrated in vacuo. The crude product was purified by column chromatography on silica gel (petroleum ether/ethyl acetate = 50: 1-5 : 1), to yield the desired product as a yellow? solid (750 mg, 63.37percent). MI R (400 MHz, CDC13): δ 10,70 (s„ 1 H) 8.16 (s, 1 H) 4.14 (s, 3 H).
55% With N-chloro-succinimide In N,N-dimethyl-formamide at 20℃; for 48 h; Example 14: Synthesis of Compound XIII-12; Step 1: Synthesis of 2,4,5-trichloro-7H-pyrrolo[2,3-d]pyrimidine (2); 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine ( 1 , 2 g, 10.6 mmol) was dissolved in DMF ( 10 mL), NCS (2.13 g, 15.9 mmol) was added and stirred at RT for 48 h. Ice was added to the reaction mixture, scratched the solid, filtered and dried to afford 2,4,5-trichloro-7H-pyrrolo[2,3-d]pyrimidine (2, 1.29 g, 55percent). NMR (400 MHz, DMSO): δ 13.15 (s, 1 H, D20 exchangeable), 7.95 (s, I H).

Reference: [1] Chemistry - A European Journal, 2015, vol. 21, # 34, p. 11976 - 11979
[2] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 5, p. 584 - 589
[3] Patent: WO2016/130920, 2016, A2, . Location in patent: Page/Page column 115
[4] Patent: WO2018/4306, 2018, A1, . Location in patent: Page/Page column 127
[5] Organic Letters, 2016, vol. 18, # 9, p. 1976 - 1979
[6] Journal of the American Chemical Society, 2014, vol. 136, # 19, p. 6908 - 6911
[7] Patent: WO2017/87905, 2017, A1, . Location in patent: Page/Page column 170
[8] Patent: WO2011/140338, 2011, A1, . Location in patent: Page/Page column 75
[9] Helvetica Chimica Acta, 2008, vol. 91, # 6, p. 1083 - 1105
[10] Patent: US2010/204221, 2010, A1, . Location in patent: Page/Page column 18
  • 3
  • [ 90213-66-4 ]
  • [ 1053228-29-7 ]
  • [ 1053228-28-6 ]
Reference: [1] Helvetica Chimica Acta, 2008, vol. 91, # 6, p. 1083 - 1105
  • 4
  • [ 39929-79-8 ]
  • [ 1053228-28-6 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 5, p. 584 - 589
[2] Patent: WO2016/130920, 2016, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1053228-28-6 ]

Chlorides

Chemical Structure| 115093-90-8

[ 115093-90-8 ]

4,5-Dichloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.92

Chemical Structure| 90213-66-4

[ 90213-66-4 ]

2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.90

Chemical Structure| 938443-20-0

[ 938443-20-0 ]

2,4,7-Trichloropyrido[2,3-d]pyrimidine

Similarity: 0.84

Chemical Structure| 746671-61-4

[ 746671-61-4 ]

4,6-Dichloropyrido[2,3-d]pyrimidine

Similarity: 0.84

Chemical Structure| 126728-20-9

[ 126728-20-9 ]

2,4-Dichloropyrido[2,3-d]pyrimidine

Similarity: 0.84

Related Parent Nucleus of
[ 1053228-28-6 ]

Other Aromatic Heterocycles

Chemical Structure| 115093-90-8

[ 115093-90-8 ]

4,5-Dichloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.92

Chemical Structure| 90213-66-4

[ 90213-66-4 ]

2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.90

Chemical Structure| 938443-20-0

[ 938443-20-0 ]

2,4,7-Trichloropyrido[2,3-d]pyrimidine

Similarity: 0.84

Chemical Structure| 746671-61-4

[ 746671-61-4 ]

4,6-Dichloropyrido[2,3-d]pyrimidine

Similarity: 0.84

Chemical Structure| 126728-20-9

[ 126728-20-9 ]

2,4-Dichloropyrido[2,3-d]pyrimidine

Similarity: 0.84